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Minneapolis, Minnesota.BACKGROUND Pulmonary vein isolation with phased radiofrequ-
ency current and use of a pulmonary vein ablation catheter (PVAC)
has recently been associated with a high incidence of clinically
silent brain infarcts on diffusion-weighted magnetic resonance
imaging and a high microembolic signal (MES) count detected by
transcranial Doppler.
OBJECTIVE The purpose of this study was to investigate the
potential correlation between different biophysical parameters of
energy delivery (ED) and MES generation during PVAC ablation.
METHODS MES counts during consecutive PVAC ablations were
recorded for each ED and time stamped for correlation with temper-
ature, power, and impedance data from the GENius 14.4 generator.
Additionally, catheter–tissue contact was characterized by the
template deviation score, calculated by comparing the temperature
curve with an ideal template representing good contact, and by the
respiratory contact failure score, to quantify temperature variations
indicative of intermittent contact due to respiration.
RESULTS A total of 834 EDs during 48 PVAC ablations were
analyzed. A signiﬁcant increase in MES count was associated with
a lower average temperature, a temperature integral over 621C, aThe study was partially sponsored by Medtronic Inc. Drs. Condie and
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Open access under CC BY-NC-ND license.higher average power, the total energy delivered, higher respiration
and template deviation scores (Po.0001), and simultaneous ED to
the most proximal and distal poles of the PVAC (P o.0001).
CONCLUSION MES generation during ablation is related to differ-
ent indicators of poor electrode–tissue contact, the total power
delivered, and the interaction between the most distal and the most
proximal electrodes.
KEYWORDS Atrial ﬁbrillation; Pulmonary vein isolation; GENius
generator; PVAC catheter; Cerebral microembolization; Transcranial
Doppler
ABBREVIATIONS ACT ¼ activated clotting time; AF ¼ atrial
ﬁbrillation; DW ¼ diffusion weighted; ED ¼ energy delivery;
LA ¼ left atrium; MCA ¼ middle cerebral artery; MES ¼ microembolic
signal; MRI ¼ magnetic resonance imaging; PVAC ¼ pulmonary
vein ablation catheter; PVI ¼ pulmonary vein isolation; RF ¼
radiofrequency; SCI ¼ silent cerebral ichemia; TCD ¼ transcranial
Doppler
(Heart Rhythm 2014;11:977–983) I 2014 Published by Elsevier Inc. on
behalf of Heart Rhythm Society. Open access under CC BY-NC-ND license.Introduction
Pulmonary vein isolation (PVI) is an established method for
treatment of atrial ﬁbrillation (AF), with a relatively low risk
(o1%) of clinical stroke or transient ischemic attack.1
However, clinically silent cerebral ischemia (SCI) can be
detected by diffusion-weighted (DW) MRI in 5% to 40% of
patients, depending on the ablation technology used.2–7 The
highest incidence of SCI during PVI has been reported with
the use of phased radiofrequency (RF) and circular multi-
polar pulmonary vein ablation catheter (PVAC).6,7 AlthoughDW MRI is the gold standard for demonstration of cerebral
lesions postablation, transcranial Doppler (TCD) can be used
to detect microembolic signals (MES) in the middle cerebral
arteries (MCAs) during the procedure. In line with the MRI
results, we previously detected a signiﬁcantly higher number
of MESs during PVAC ablations than with the use of a
cryoballoon. Importantly, the majority of MESs were dem-
onstrated to be generated during the energy delivery (ED)
phase of PVAC ablations.8
Limited data regarding the mechanism of MES generation
during RF ablation are available. In this study, we compared
the MES counts recorded during ED with the high-resolution
biophysical data collected from the generator during phased
RF ablation in a consecutive series of patients. We hypothe-
sized that some biophysical data speciﬁc to this multi-
electrode ablation technology were potentially related to
microembolization. These included the number of electrodes. http://dx.doi.org/10.1016/j.hrthm.2014.03.018
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neous use of the most proximal and the most distal electrodes
during RF applications, and metrics indicating poor or
variable electrode–tissue contact.
Methods
Study population and patient preparation
Forty-eight consecutive patients undergoing PVI for sympto-
matic paroxysmal or persistent AF not adequately controlled
by at least 1 antiarrhythmic drug were eligible for inclusion in
the study. Exclusion criteria included long-standing persistent
AF, known bleeding disorders, and a contraindication to oral
anticoagulation. The study conformed with the guiding
principles of the Declaration of Helsinki and was approved
by the Institutional Ethics Committee. All patients provided
written informed consent prior to inclusion in the study.
On the day before ablation, transesophageal echocardio-
graphy was performed to exclude the presence of a cardiac
thrombus. All patients received oral anticoagulation before
PVI, with a target international normalized ratio of 2.0 to 3.0,
which was maintained for the procedure.
Ablation protocol
All procedures were performed with the patient under con-
scious sedation using midazolam and fentanyl. The ablation
protocol was performed as reported previously.8 In brief,
decapolar and quadripolar catheters were advanced from the
femoral vein and positioned in the coronary sinus and the right
ventricle. A single transseptal puncture was performed under
ﬂuoroscopic and intracardiac echocardiographic guidance
using standard technique. A deﬂectable 12Fr sheath (Flex-
Cath, Medtronic CryoCath LP, Kirkland, Quebec, Canada)
was used in the left atrium (LA) and ﬂushed continuously with
heparinized saline. This sheath was used to guide the PVACFigure 1 Position of the pulmonary vein ablation catheter during energy d
interelectrode distance compared with the distance between the nonmodiﬁable po(Ablation Frontiers, Medtronic, Carlsbad, CA). Immediately
before transseptal puncture, an IV heparin bolus 150 IU/kg
body weight was given, followed by continuous infusion to
maintain a minimum activated clotting time (ACT) target level
of 350 seconds. ACT was always checked prior to the ﬁrst
ablation and every 20 minutes thereafter. Additional 2000–
5000 IU IV boluses of heparin were administered as required
to reach the minimum target ACT level.
The PVAC was connected to a duty-cycled RF generator
(GENius 14.4, Ablation Frontiers, Medtronic). The system is
capable of ED in a temperature-controlled mode with
simultaneous application on all or any of a selected number
of the 10 electrodes. All ablations were performed at a 601
temperature goal for 1 minute and a maximum power of
10 W. Of note, there is a possibility of signiﬁcant interaction
of the current densities in electrodes 1 (E1) and 10 (E10)
when they are in close proximity,9 as evidenced by an
impedance drop o110 Ω.10 Therefore, simultaneous ED on
these poles was attempted only after ﬂuoroscopic assessment
of the interelectrode distance, which was considered adequate
if the space between E1 and E10 was at least double the usual
3-mm interelectrode distance as assessed from multiple
views. Examples of a satisfactory catheter position and one
where E1 and E10 were too close are shown in Figure 1. RF
energy was applied for 60 seconds, usually 3–4 times per PV
starting with a bipolar/unipolar ratio of 4:1. Any electrode
pair that failed to reach at least 501C during RF delivery was
switched off to avoid ineffective ED due to improper contact
at the electrode–tissue interface. Furthermore, when any
electrode reached the target temperature while delivering
very low power (1–2 W), it was considered a sign of an
undesirably strong electrode–tissue contact or a wedge
position of the electrode, and ED to that particular electrode
was switched off. The end-point was electrical isolation of all
PVs as conﬁrmed by demonstration of entrance block.elivery. A: Optimal catheter position ensuring at least a doubleE1–E10
les. B: Catheter position where E1 and E10 are unsafely close.
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TCD recording was performed throughout the period of LA
access. The transducer was held in place by a proprietary
headpiece supplied with the system. The MCAs were
insonated bilaterally from transtemporal windows using multi-
frequency Doppler (Multi Dop T digital, DWL, QL software
2.8). TCD parameter settings recommended by the Consensus
Criteria were maintained constant during the procedures.11
Insonation depth was 45 to 55 mm, sample volume was 8 mm,
and power was 60 to 100 mW. MES counts were recorded for
each ED and time stamped to correlate with the high-
resolution power and temperature parameters collected from
the GENius 14.4 generator for ofﬂine analysis.Data collection from the GENius 14.4 generator
Generator ﬁles for each ablation during the procedure were
collected. The ﬁles included information on the ablation
(mode, electrodes enabled), the power for each electrode
sampled at 1 Hz, and the temperature for each electrode
sampled at 8 Hz. Parameters analyzed ofﬂine for potential
correlation with MES data included the bipolar/unipolar ratio,
the average power delivered, the total energy delivered, the
number of electrodes on during the ED, the simultaneous use
of E1 and E10, the average temperature, and the presence of
temperature overshoot. Temperature overshoot was deﬁned as
Z621C during the ED, and the integral over 621C was
calculated as the area under the temperature curve above 621C.
For evaluation of electrode–tissue contact, 2 additional
metrics were calculated. The respiratory contact failure score
was based on the analysis of temperature variability at
respiration frequency in order to quantify improper contactFigure 2 Respiration-related temperature variability. Temperature signal oscill
marker of intermittent contact at respiratory frequency (red lines). The absolute valu
electrodes, with the highest scores for electrodes 6, 9, and 10.attributed to respiratory movements (Figure 2). This score was
calculated for each electrode by ﬁltering the temperature signal
and then calculating the power spectrum at the respiration
frequency between 10 and 20 breaths/min. The other parameter
was the template deviation score, which compared the actual
temperature curve during ablation with an ideal template. The
ideal template was created from in vitro results featuring a quick
temperature rise with the target temperature of 601C reached
within 20 seconds, followed by a steady state for the remainder
of the ablation. Template deviation was considered negative in
the case of a slow rise or if the temperature remained o601C
and was considered positive for a quick temperature rise and a
temperature 4601C. This concept is outlined in the Online
Supplementary Figure 1, with real examples of an ideal
temperature curve and a negative deviation shown in
Figure 2. Template deviation scores were calculated as the
sum of the squared errors between the real electrode temperature
and the ideal template at each time point for each electrode
during ED. The score for each RF delivery representing the
mean of the electrodes was related to the MES count.Statistical analysis
Gaseous and solid signal counts were summed (total MES).
Because bilateral recording of MCA was not possible in all
cases, mean MES counts per MCA were calculated using
either the mean of the bilateral counts when both sides were
measured or the unilateral data when only 1 side was
available To improve normality, signal count data were
natural log-transformed, and ablation parameters were trans-
formed by using whichever formula (square, square root, or
natural log) provided the closest ﬁt to a normal distribution.ation can be seen in the temperature curves of electrodes 6, 9, and 10 as a
es of the respiratory contact failure score are also indicated for each of the 10
Figure 4 Association of the total energy delivered on all active electrodes
with the microembolic signal (MES) count. CI ¼ conﬁdence interval.
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count were descriptively quantiﬁed using unadjusted Pearson
correlation coefﬁcients (r) as a ﬁrst approach.
For in-depth analysis, multilevel mixed-effects linear
regression was used to evaluate the effect of ablation para-
meters on the total MES count. Models were adjusted for total
energy delivered and average temperature. Interaction terms
were used to assess effect heterogeneity across levels of
potential effect-modifying factors. Fixed effects were
expressed as estimated differences in the log-transformed
outcome, 95% conﬁdence intervals, and P values. Model
checking was based on inspection of the normality of residuals.
Applications were excluded from the analysis if tempo-
rary signal problems on TCD occurred. Additionally, energy
delivery sessions interrupted earlier than 40 seconds were
excluded from the respiratory contact failure, the template
deviation, and the number of active electrodes analyses.
P o.05 was considered signiﬁcant. The statistical pack-
age Stata (StataCorp 2009, Stata Statistical Software Release
11, StataCorp LP, College Station, TX) was used for
statistical analysis.Results
A total of 834 RF application sessions were performed
during phased RF ablation with the PVAC in 48 patients. All
patients had an international normalized ratio 42.0 con-
ﬁrmed on the day of the procedure. Six patients had values
slightly43.0 buto4. Bilateral TCD recording could not be
achieved in 5 patients. The right side was missing on 4 of
these patients, whereas the left side was missing in 1 patient.
The mean MES count per ablation did not differ signiﬁcantly
in the unilateral group compared to patients with bilateral
TCD monitoring (22 SD:32 vs 28 SD:48 mean MES per
ablation, respectively, P 4.05).
The number of concomitantly active electrodes during ED
was found to increase the MES count signiﬁcantly (Pearson
correlation coefﬁcient r ¼ 0.252, adjusted P o.0001;
Figure 3). Accordingly, increase of the total energy delivered
to all active poles correlated with an increase in MES count
(Pearson correlation coefﬁcient r ¼ 0.340, adjusted
P o.0001; Figure 4).Figure 3 Microembolic signal (MES) count and the number of active
electrodes. CI ¼ conﬁdence interval.RF energy was delivered simultaneously on E1 and E10
in 285 instances with an impedance dropo110 Ω observed
in 3 cases. Concomitant use of E1 and E10 resulted in
signiﬁcantly higher MES counts than in ablations where
these 2 poles were not coactive (mean MES per patient 36.3
SD:51.4 vs mean MES 23.8 SD:38.3, Pearson correlation
coefﬁcient r ¼ 0.160, adjusted P o.0001).
Both lower average temperatures (range 451–551C) and a
higher temperature integral over 621C resulted in an increa-
sed MES count (Pearson correlation coefﬁcient r ¼ 0.257,
0.145, respectively, adjusted P o.0001; Figure 5). More-
over, higher temperature integrals over 621C were found in
those ablations where the average temperature was in the
range from 451 to 551C.
Positive template deviation scores did not affect the MES
count (Pearson correlation coefﬁcient r ¼ 0.110, adjusted
P ¼ 0.342). Negative template deviation scores were
associated with an increase in MES count (Pearson correla-
tion coefﬁcient r ¼ 0.323, adjusted P o.0001; Figure 6).
Higher respiratory contact failure was associated with higher
MES count (Pearson correlation coefﬁcient r ¼ 0.165,
adjusted P ¼ 0.0002; Figure 7, left), whereas an inverse
relationship was found between the respiratory contact failure
score and the average temperature (Pearson correlation
coefﬁcient r ¼ 0.389, adjusted P o.0001; Figure 7, right).
No signiﬁcant relationship was found between the MES
count and the bipolar/unipolar ablation mode. Mean MES
per patient: 26.7 SD:43.6, 28.2 SD:44.3, and 25.2 SD:28.37
were found during EDs with 4:1, 2:1, and 1:1 bipolar/
unipolar modes, respectively (Pearson correlation coefﬁcient
r ¼ 0.051, adjusted P ¼ .35).
Discussion
Recent reports of SCI during catheter ablation for AF raised
concern regarding the safety of these procedures. Although
several clinical and procedural predictors of both manifest
and silent cerebral embolization have been identiﬁed, the
direct correlation between thrombus formation and the
biophysical parameters during RF ED in the LA is poorly
understood. Our data, collected at a high sampling rate from
the GENius 14.4 generator with simultaneous recording of
Figure 5 Effects of average temperature (left) and temperature integral over 621C (right) on the microembolic signal (MES) count. CI¼ conﬁdence interval.
Figure 6 Association of template deviation score with microembolic
signal (MES) count. CI ¼ conﬁdence interval.
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of cerebral microembolization.
Because previous magnetic resonance data indicated that
phased RF technology with the PVAC might be more
thrombogenic compared with irrigated RF ablation, our
analysis focused on some distinctive features of this
technology.
The E1–E10 interaction is the only known predictor of
new lesions on DW MRI after phased RF ablation.9,11
Furthermore, we recently demonstrated that the number of
microemboli detected by TCD during PVI was higher with
concomitant use of E1–E10.8 This probably is due to a
reduced interelectrode distance or electrode overlap when the
PVAC loop is compressed, which may result in increased
local current density and thereby increased MES production.
Signiﬁcantly higher MES counts with coactive E1 and E10
were also demonstrated in this study despite careful ﬂuoro-
scopic assessment of electrode positions. We propose 2
possible explanations: (1) E1–E10 interaction was due to
catheter displacement resulting in a shortened E1–E10
distance during the ablation; and (2) the E1–E10 combina-
tion was used almost exclusively when most of the electrodes
also were enabled, resulting in a higher total energy delivery
that was an independent predictor of MES production in this
study. Importantly, an impedence dropo110 Ω, considered
an indication for E1–E10 interaction by Wieczorek et al,9
occurred in a negligible number of energy deliveries in
our study.
A speciﬁc feature of duty-cycled ablation with the PVAC
is RF delivery with different bipolar/unipolar mode ratios. A
study by Haines et al12 revealed signiﬁcantly lower MES
count and microembolic volume with the unipolar mode than
with any of the ED modes with a bipolar component. The
unipolar mode was not used in this study, and, in accordance
with our previous results,8 no signiﬁcant difference in MES
count was found during ED in 4:1 vs 2:1 mode.
Intermittent contact has also been proposed as a potential
mechanism of embolus formation during ED. This appears to
be the ﬁrst investigation of the role of improper tissue–
catheter contact in microembolus production during RF
ablation. It is known that lower average temperaturesachieved with a nonirrigated catheter usually indicate
improper electrode–tissue contact, and higher power is
necessary to achieve the target temperature in these instan-
ces. Moreover, in the event of intermittent contact, the power
increase during the off-contact period can lead to temper-
ature overshoot once better tissue contact is established.13
Therefore, we evaluated the average power, average temper-
ature, and temperature integral over 621C as indicators of
electrode–tissue contact. To further characterize contact
during ED, a template deviation score was used to quantify
the difference between an ideal and the real temperature.
Because contact problems may be related to respiration, a
respiratory contact failure score was also calculated to
analyze temperature variability at the respiration frequency.
All of these metrics demonstrated a signiﬁcant correlation
with embolus formation: a lower average temperature (451–
551C), a higher average power, a higher temperature integral
over 621C, a higher template deviation score, and a higher
respiratory contact failure score were independent predictors
of an increased MES count. Of note, all ablation procedures
were performed under conscious sedation in this study.
Ventilation under general anesthesia might result in different
respiratory variability and MES count.
Contact becomes especially critical when multipolar
ablation catheters are used. It is important to note that
Figure 7 Effects of respiration score on microembolic signal (MES) count (left) and temperature (right). CI ¼ conﬁdence interval. See text for details.
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tact on multiple poles, with either a circular or a linear
arrangement, may not be feasible in the majority of cases due
to the complex anatomy. Modiﬁcations in the power han-
dling of the RF generator to ensure a gradual and limited
increase during temporary no-contact scenarios, which has
been implemented in the most recent software version of the
GENius generator, may prove to be useful in avoiding high-
temperature peaks when better contact is reestablished.
Another although technically ponderous strategy that could
be beneﬁcial is the incorporation of contact force sensors in
these electrodes, which would enable the assessment of
contact before an electrode is selected for RF delivery.
Moreover, the overall delivered energy is necessarily higher
with simultaneous ablation on multiple electrodes, and our
data reveal that the higher the total energy delivered, the
greater the number of emboli. It could be argued, however,
that with the longer lesion created by applying RF to multiple
poles, fewer ED sessions are required. However, whether the
total MES count itself is related to the thrombogenic
potential of the ablation procedure or whether the intensity
of MES formation (the MES count in a given time) is of
importance is unknown.
Another problem speciﬁc to the circular catheter design is
the potential interaction between the electrodes if the circle is
compressed and the poles mounted on the proximal and
distal parts of the circle come closer to each other. A possible
solution to prevent this interaction, software regulation of the
ablator, has already been implemented in the latest version of
the GENius generator (software version 15.0), which does
not allow simultaneous ED on E1–E10. However, an
interaction between other poles in case of a wedged position
still remains possible; therefore, careful assessment of the
electrode position still is not obsolete.Study limitations
Our study has signiﬁcant limitations. This was a retrospec-
tive analysis with ofﬂine correlation of data recorded by the
RF generator and TCD. The data reﬂect only 1 technology,
with limited implications for other techniques, although
contact metrics and their relationship with embolization arelikely to apply for RF ablation in the LA, regardless of the
technology.
Conclusion
Cerebral microembolization during ED with the PVAC
catheter was associated with the total energy delivered and
several biophysical parameters that can be linked to variable
or poor electrode–tissue contact: lower average temperature,
negative template deviation score, temperature overshoots,
respiratory contact failure score, and increased average
power. Concomitant RF delivery to electrodes potentially
moving in close proximity to each other also accounts for
MES formation.
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